* Helius Medical Technologies Inc HSDT.OQ reported a
quarterly
adjusted loss of 6 cents per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 12 cents per share.
* Revenue rose 115.1% to $256.00 thousand from a year ago;
analysts expected $188.33 thousand.
* Helius Medical Technologies Inc's reported EPS for the
quarter
was a loss of 6 cents.
* The mean earnings estimate of analysts had fallen by
about 9.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Helius Medical Technologies Inc shares had fallen by 6.1%
this
quarter and lost 41.3% so far this year.
* The company reported a quarterly loss of $1.65 million.
* Wall Street's median 12-month price target for Helius
Medical
Technologies Inc is $1.70
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 10 at 09:53 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.12 -0.06 Beat
Mar. 31 2023 -0.11 -0.09 Beat
Dec. 31 2022 -0.13 -0.17 Missed
Sep. 30 2022 -0.21 -0.03 Beat